BioPartnering North America

BioPartnering North America

January 18, 2007 15:07 ET

BioPartnering North America Attracts Key Stakeholders From the International Biotech Industry

SANTA CRUZ, CALIFORNIA--(CCNMatthews - Jan. 18, 2007) -

There is now less than a month to go until this year's BioPartnering North America (BPN) which will be held in Vancouver, B.C., Canada, on February 4-6, 2007 as a partnership between Technology Vision Group LLC (TVG), BC Biotech, BioAlberta and BIOTECanada.

With well over 600 international participants now registered to attend, the 5th annual BPN conference is proving to be as popular as ever, attracting key decision makers from the biotechnology, pharmaceutical and financial industries and providing the perfect environment for biotech companies seeking potential partners and business opportunities.

Supported and sponsored annually by leading pharma, venture capital, and life science service organizations, BPN features high value discussion and perspectives from key players on the state of the biotech industry today and the evolving relationship between pharma and biotech companies.

This year's BPN will also feature an informative presentation and corporate strategy update from Procter and Gamble, the world's leading consumer products company. Jeff Davis, Head of Global New Business Development for Procter & Gamble Pharmaceuticals will discuss "Connect and Develop", the Company's new campaign for accelerating internal research and development efforts by seeking to leverage ideas, talents, and innovation assets of a wide diversity of individuals, institutions, and companies from around the world.

Other highlights of the conference program include:

- 56 Open House presentations - interactive presentations in specially constructed booths to allow informal discussion

- 20 Emerging Company presentations - young companies in 14 minute podium presentations

- 5 BioPartnering Leadership Sessions - senior executives from the financial, pharma, and biotech industries address cutting edge themes of the day in panel discussions

- 7 Sponsor Workshops - leading service providers offer 1 hour workshops on unique topics in an interactive environment

- Networking opportunities - including a special opening reception on Sunday, February 3rd and a dinner on Monday, February 4th

- - BPN's state-of-the-art partnering system allowing delegates to organize their time more efficiently and in advance of the event.

Registrations are still being accepted for BPN at

Media registration is also available and is complimentary for accredited members of the news media. To register for BPN, or for further information please contact Helena Galilee or Valerie Auffray (; at Citigate Dewe Rogerson.

Conference Sponsors

Angiotech Pharmaceuticals, Inc., AstraZeneca, PricewaterhouseCoopers, Province of British Columbia, Cooley Godward Kronish LLP, Farris, Vaughan, Wills & Murphy LLP, Ferghana Partners Group, Morrison & Foerster, Pfizer, Wyeth, Bristol-Myers Squibb Company, Italian Trade Commission, Merck & Co., Inc., NovaQuest, Novartis, Procter and Gamble, QLT Inc., Roche, Seed Intellectual Property Law Group PLLC, UK Trade & Investment, anapharm, BC Innovation Council, BioWa, Inc., Genome British Columbia, Hong Kong Science and Technology Parks, Life Science Analytics, Marsh Canada Limited, UBC University - Industry Liaison Office

Conference Supporters

Bio Business, BioExecutive International, Biotechnology Focus, BioWorld Today, CCNMatthews , Citigate Dewe Rogerson, Contact Canada®, European Biopharmaceutical Review, Nature Biotechnology, U.S. Commercial Service, Washington Biotechnology & Biomedical Association, Global Bioscience Partnership

2007 Emerging Company Presenters

Abeome Corp., Amkor Pharma, Inc., Aquinox Pharmaceuticals, Clone-E Therapeutics, Colby Pharmaceuticals, EUSA Pharma Inc., FoldRx Pharmaceuticals, GammaCan Int. Inc., Jennerex Biotherapeutics Inc., Kinexis Inc., MAP Pharmaceuticals, Matregen Corp., Merrion Pharmaceuticals Limited, Mimetica Pty Ltd., Nerities Corporation, PainCeptor Pharma Corp., Royalmount Pharma, Sernova Corp., Taligen Therapeutics, TransOral Pharmaceuticals Inc.

2007 Open House Presenters

Aegera Therapeutics Inc., Affibody, Alphora Research Inc., Aspreva Pharmaceuticals, Athenagen, Avid Bioservices, Axela Biosensors Inc., BioWa, Inc., BIOZONA, Borean Pharma ApS, Cell Genesys, Inc., Celldex Therapeutics, Centre for Translational and Applied Genomics, ChemokineTherapeutics, CombinatoRx, Critical Outcome Technologies Inc., Curis Inc., Cytokinetics, Inc., decode Chemistry & Biostructures, enGene, Enzo Therapeutics, Inc., Epeius Biotechnologies Corporation, F2G Limited, Forbes Medi-Tech Inc., Genizon BioSciences, Hunter-Fleming Limited, Ichor Medical Systems, Inc., INC Research, Ingenium Pharmaceuticals AG, Inimex Pharmaceuticals, Inc., InNexus Biotechnology Inc., KAI Pharmaceuticals, Lorus Therapeutics, Inc., MaxCyte, Inc., Miltenyi Bioprocess, NAL Pharmaceuticals Ltd., NascaCell Technologies AG, Naviscan PET Systems, NPIL Pharma Torcan, Ondine BioPharma, Orphan Australia Pty Ltd, Patheon Inc., PIERIS AG, Resverlogix Corp., SemBioSys, SR Pharma plc. / Atugen AG, Stem Cell Therapeutics, Syntaxin, TopoTarget UK Ltd., Tripos Discovery Research, Vertical i, Inc., Virxsys Corporation, Welichem Biotech Inc., XOMA Ltd., Xytis, ZIOPHARM Oncology, Inc.

Contact Information